GW Rad Onc in Washington DC has an opening for a physician faculty position focused on GI and Thoracic cancers. Join our vibrant growing cancer center in an unbeatable urban location. PM me for details or email CV to our Director, Dr. Sharad Goyal.

gwu.jobs/postings/103839

Pleased to report the publication of the 5th MARCAP analysis, BCRSCRAP, in Journal of Clinical Oncology today! ascopubs.org/doi/full/10.12… Led by SOUMYAJIT ROY and Tahmineh Romero UCLA Jonsson Comprehensive Cancer Center

Excited to share our new pub reporting on a PI3K-AKT-mTOR gene expression signature predicting local failure and DFS after SBRT for early-stage #lungcancer (NSCLC). A job well done by Nikhil and team building on our preclinical data! #radbio #radonc #LCSM
acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

🎙️Proton may be more effective and safer than photon therapy for 🫂 w/ #esophagealcancer ‼️ OncoAlert JAMA Network Open
📌 Meta-analysis studies w/ dosimetric/prognosis/and toxic effects outcomes
🥇🎯:Proton vs. photon therapy efficacy and safety;
📊RESULTs
👉Proton ⬇️ OARs…

IDH Wildtype Astrocytoma, does isolated TERT Promoter Mutation in histologic Grade 2 equate to GBM prognosis?

Probably NOT, isolated TERT have better prognosis pubmed.ncbi.nlm.nih.gov/34343326/

Simul Parikh Many good points. As recovering workaholic looking back on the years the hours were off the rails only fills me with regret. It is good to work hard most of us like to but there has to be a balance

PDBrown Simul Parikh Means a lot coming from one of the top and most influential CNS rad oncs globally. But we still need to finish our adult CNS rad onc book (2ed)😎. Though I’m not of that caliber, I’ve also stopped being a workaholic. Work-life balance is crucial.

No OS benefit to adding docetaxel to RT+ADT in (very) high-risk M0 #ProstateCancer

Per our colleague’s request, I attached here the Abstract of WCLC 2023 about MDT consensus survey study. Please join us “to resect or not to resect” discussion in Singapore on 9/10/23.

Dr. Perez will be missed greatly! He conducted RTOG 73-01 randomized study and established 60 Gy as SOC for medical inoperable stage II/III NSCLC and this remains the standard RT dose we use 43 years after his paper published in Cancer in 1980 when I was a college student.

Stereotactic body radiotherapy for hepatocellular carcinoma: meta-analysis and International Stereotactic Radiosurgery Society practice guidelines - International Journal of Radiation Oncology, Biology, Physics redjournal.org/article/S0360-…

Attention RadOnc residents! ARRO EISC & SWRO present to you The Job Hunt Fireside Chat Webinar. Come hear from recent graduates about their experience and tips to finding a job in RadOnc!

Sign up below!
docs.google.com/forms/d/e/1FAI…

🎙️Adjuvant fRT may be associated with improved PFS post-fRT compared to salvage fRT in #meningiomas ‼️ OncoAlert Radiotherapy & Oncology
📌Multi-institutional cohort of intracranial meningioma 🫂 treated w/ fRT
🥇🎯: outcomes & factors 🔄PFS w/ adjuvant OR salvage RT
📊RESULTS
👉404…

Inspired by my good friends eviCore healthcare, who are basically wealth managers for UnitedHealthcare: I would remind my fellow RadOncs to ALWAYS appeal, and then appeal the P2P. Don't forget that CMS contracts with Maximus (IRE) - and we have data now. eviCore has ~4x more overturns than average:

Abstract Summary:

Oligometastatic head and neck cancer treated w/ SBRT (42 patients). Control rate for treated metastasis was 80% at 1 yr, 66% at 2 yrs. The avg time before recurrence was 10 mos, median survival times w/o progression and overall were 4.7 and 23.3 months,

Please tell Dr Spratt and many of our academics in the USA that Abiraterone is cheap

(I'd tell him myself, but he blocked me because I once said it was cheap 🤑)

What do u suggest for 2nd-line after progression on Osimertinib in EGFR mt #lungcancer ADC? Tumor markers are rising but patient is asymptomatic. He presented with widespread bone met & multiple brain mets. Based on PET organ of progression is bone. Brain is controlled. #lcsm

Thoughtful editorial by Dr. Nina Niu Sanford Simul Parikh Matt Spraker

Pertinent ONGOING trial NRG BN005 IDHm Protons vs. IMRT
jamanetwork.com/journals/jamao…

🎙️ #SBRT is an effective treatment modality for #HCC patients with mature follow up❗️OncoAlert IJROBP - The Red Journal congrats Alex Louie MD, PhD
📌SR & MA on outcomes and hepatic toxicity rates after SBRT for liver-confined HCC
📊RESULTS
👉17 observational 📝 w/ 1889 👥
👉3-y OS SBRT: 57% (CI:…

If you thought PSMA PET always led to stage migration, you might want to think again. At initial staging over half of patients with bone mets on bone scan were negative on PSMA PET. Sometimes increased accuracy leads to fewer mets! Check it out from JNM: bit.ly/3qLnMWO